HRG reviewed nine products in the health category, 48 in the wellness sector and 32 items in the beauty aisle to see which ones stood out as Products to Watch.
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the United States, subject to regulatory approval, no later than Feb. 21, 2025.
The COcoa Supplement and Multivitamin Outcomes Study included two separate clinical trials testing multivitamin supplementation on changes in cognitive function.
